Creation of ARM Foundation Aims to Educate, Empower Public

0

Advancement of cell and gene medicines is stated goal of Alliance for Cell and Gene Medicine

The Alliance for Regenerative Medicine (ARM) recently announced the launch of the ARM Foundation for Cell and Gene Medicine.

This independent, 501(c)(3) non-profit organization is dedicated to increasing public awareness and understanding of the clinical and societal benefits of cell and gene medicine and has added this latest venture to its ongoing efforts to accelerate patient access to safe, effective, and potentially curative gene therapies, and supporting its development through education and research projects.

The goal of the newly formed ARM Foundation for Cell and Gene Medicine is to educate, engage, and empower the public and stakeholders on key scientific, clinical, and regulatory issues that affect the advancement and acceptance of cell and gene medicines as viable and transformative treatment options.

“Gene medicine is advancing at an unprecedented pace with potential to benefit millions of patients with incurable diseases,” said Janet Lynch Lambert, CEO of ARM. “The foundation will help accelerate the public understanding and acceptance necessary for society to fully benefit from this exciting science.”

“The ARM Foundation will serve as a resource for people to learn about gene therapy, gene editing, and cells as medicines and to help dispel common misconceptions. Through educational efforts that inform the public, media, and others on more balanced and less sensational developments in cell and gene medicine, we hope to increase acceptance of these technologies, engage more people in the clinical trial process, and help expedite the development of life-saving therapies,” said Stewart Parker, the former CEO of Targeted Genetics and board chairperson for the ARM Foundation.

Share.

271 words

About Author

Rob Senior
Rob Senior

Rob has 15 years of experience writing and editing for healthcare. He previously worked for ADVANCE from 2002 to 2012.

Leave A Reply

Log in or register to comment on this article.